With FDA’s Help, Firms Move Microarray-based Tests Into The Clinic
This article was originally published in The Gray Sheet
Executive Summary
FDA and manufacturers are working together to come up with data analysis standards and other best practices to ensure that microarray-based technologies work consistently in real-world clinical settings